|
Market Cap (20-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 27 June 2022, 10:10. The announcement is marked as price sensitive, and is 3 page(s) in length and 227.72kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| NanaBis Independently Confirmed BioAvailability | 27 June 2022, 10:10 |
| Medlab signs exclusive commercial agreement with YesHealth | 23 June 2022, 8:22 |
| Progression of NanoCelle NASAL COVID-19 Vaccine Program | 31 May 2022, 12:18 |
| Biotech Investors Luncheon Presentations | 16 May 2022, 15:34 |
You must be logged in to post a reply.
Medlab Clinical 